Warfarin Glycosylation Invokes a Switch from Anticoagulant to Anticancer Activity

Overview

Journal ChemMedChem

Specialties Chemistry
Pharmacology

Date 2011 Jun 30

PMID 21714096

Citations 12

Authors

Pauline Peltier-Pain

Shannon C Timmons

Agnes Grandemange

Etienne Benoit

Jon S Thorson

Affiliations

Soon will be listed here.

Citing Articles

A Small Sugar Molecule with Huge Potential in Targeted Cancer Therapy.

Pastuch-Gawolek G, Szreder J, Dominska M, Pielok M, Cichy P, Grymel M Pharmaceutics. 2023; 15(3).

PMID: 36986774 PMC: 10056414. DOI: 10.3390/pharmaceutics15030913.

A sustainable innovation for the tandem synthesis of sugar-containing coumarin derivatives catalyzed by lipozyme TL IM from in continuous-flow microreactors.

Du L, Chen P, Long R, Xue M, Luo X RSC Adv. 2022; 10(22):13252-13259.

PMID: 35492096 PMC: 9051562. DOI: 10.1039/d0ra00879f.

Synthesis of MeON-Glycoside Derivatives of Oleanolic Acid by Neoglycosylation and Evaluation of Their Cytotoxicity Against Selected Cancer Cell Lines.

Du Z, Li G, Zhou X, Zhang J Molecules. 2021; 26(3).

PMID: 33540945 PMC: 7867353. DOI: 10.3390/molecules26030772.

Targeting Iron in Colon Cancer via Glycoconjugation of Thiosemicarbazone Prochelators.

Akam E, Tomat E Bioconjug Chem. 2016; 27(8):1807-12.

PMID: 27471913 PMC: 8221252. DOI: 10.1021/acs.bioconjchem.6b00332.

The identification of perillyl alcohol glycosides with improved antiproliferative activity.

Nandurkar N, Zhang J, Ye Q, Ponomareva L, She Q, Thorson J J Med Chem. 2014; 57(17):7478-84.

PMID: 25121720 PMC: 4161159. DOI: 10.1021/jm500870u.

References

Kim H, Yen C, Preston P, Chin J . Substrate-directed stereoselectivity in vicinal diamine-catalyzed synthesis of warfarin. Org Lett. 2006; 8(23):5239-42. DOI: 10.1021/ol062000v. View

Valente E, LINGAFELTER E, Porter W, TRAGER W . Structure of warfarin in solution. J Med Chem. 1977; 20(11):1489-93. DOI: 10.1021/jm00221a025. View

Chan E, McLachlan A, OReilly R, Rowland M . Stereochemical aspects of warfarin drug interactions: use of a combined pharmacokinetic-pharmacodynamic model. Clin Pharmacol Ther. 1994; 56(3):286-94. DOI: 10.1038/clpt.1994.139. View

Zielinska A, Lichti C, Bratton S, Mitchell N, Gallus-Zawada A, Le V . Glucuronidation of monohydroxylated warfarin metabolites by human liver microsomes and human recombinant UDP-glucuronosyltransferases. J Pharmacol Exp Ther. 2007; 324(1):139-48. PMC: 2275122. DOI: 10.1124/jpet.107.129858. View

Peri F, Deutman A, La Ferla B, Nicotra F . Solution and solid-phase chemoselective synthesis of (1-6)-amino(methoxy) di- and trisaccharide analogues. Chem Commun (Camb). 2002; (14):1504-5. DOI: 10.1039/b203605c. View

Oldenburg J, Watzka M, Rost S, Muller C . VKORC1: molecular target of coumarins. J Thromb Haemost. 2007; 5 Suppl 1:1-6. DOI: 10.1111/j.1538-7836.2007.02549.x. View

Langenhan J, Peters N, Guzei I, Hoffmann F, Thorson J . Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization. Proc Natl Acad Sci U S A. 2005; 102(35):12305-10. PMC: 1194917. DOI: 10.1073/pnas.0503270102. View

Dwek R . Glycobiology: Toward Understanding the Function of Sugars. Chem Rev. 1996; 96(2):683-720. DOI: 10.1021/cr940283b. View

Begent L, Hill A, Steventon G, Hutt A, Pallister C, Cowell D . Characterization and purification of the vitamin K1 2,3 epoxide reductases system from rat liver. J Pharm Pharmacol. 2001; 53(4):481-6. DOI: 10.1211/0022357011775776. View

10.

Langenhan J, Engle J, Slevin L, Fay L, Lucker R, Smith K . Modifying the glycosidic linkage in digitoxin analogs provides selective cytotoxins. Bioorg Med Chem Lett. 2008; 18(2):670-3. DOI: 10.1016/j.bmcl.2007.11.058. View

11.

Griffith B, Krepel C, Fu X, Blanchard S, Ahmed A, Edmiston C . Model for antibiotic optimization via neoglycosylation: synthesis of liponeoglycopeptides active against VRE. J Am Chem Soc. 2007; 129(26):8150-5. DOI: 10.1021/ja068602r. View

12.

Xie J, Yue L, Chen W, Du W, Zhu J, Deng J . Highly enantioselective michael addition of cyclic 1,3-dicarbonyl compounds to alpha,beta-unsaturated ketones. Org Lett. 2007; 9(3):413-5. DOI: 10.1021/ol062718a. View

13.

Rettie A, Tai G . The pharmocogenomics of warfarin: closing in on personalized medicine. Mol Interv. 2006; 6(4):223-7. DOI: 10.1124/mi.6.4.8. View

14.

Holemann A, Seeberger P . Carbohydrate diversity: synthesis of glycoconjugates and complex carbohydrates. Curr Opin Biotechnol. 2004; 15(6):615-22. DOI: 10.1016/j.copbio.2004.10.001. View

15.

Cain D, Hutson S, Wallin R . Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane. J Biol Chem. 1997; 272(46):29068-75. DOI: 10.1074/jbc.272.46.29068. View

16.

Tsuchiya Y, Hamashima Y, Sodeoka M . A new entry to Pd-H chemistry: catalytic asymmetric conjugate reduction of enones with EtOH and a highly enantioselective synthesis of warfarin. Org Lett. 2006; 8(21):4851-4. DOI: 10.1021/ol0619157. View

17.

Goff R, Thorson J . Enhancing the divergent activities of betulinic acid via neoglycosylation. Org Lett. 2008; 11(2):461-4. PMC: 2704577. DOI: 10.1021/ol8025704. View

18.

Bobek V, Kovarik J . Antitumor and antimetastatic effect of warfarin and heparins. Biomed Pharmacother. 2004; 58(4):213-9. DOI: 10.1016/j.biopha.2003.11.007. View

19.

Kamali F, Wynne H . Pharmacogenetics of warfarin. Annu Rev Med. 2009; 61:63-75. DOI: 10.1146/annurev.med.070808.170037. View

20.

Halland N, Hansen T, Anker Jorgensen K . Organocatalytic asymmetric Michael reaction of cyclic 1,3-dicarbonyl compounds and alpha,beta-unsaturated ketones--a highly atom-economic catalytic one-step formation of optically active warfarin anticoagulant. Angew Chem Int Ed Engl. 2003; 42(40):4955-7. DOI: 10.1002/anie.200352136. View